These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2179102)

  • 21. Treatment of agitation in bipolar disorder across the life cycle.
    Alderfer BS; Allen MH
    J Clin Psychiatry; 2003; 64 Suppl 4():3-9. PubMed ID: 12672259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new clinical protocol for the pharmacological management of acute behavioural disturbance.
    Emmerson B; Moudgil V; Woodbridge A; Burrows D; Kingswell B; Kubler P; McMahon K
    Australas Psychiatry; 2011 Oct; 19(5):406-9. PubMed ID: 21995354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant use of Lorazepam with tamoxifen in bipolar mania clinical trials.
    Kruszewski SP; Paczynski R
    Arch Gen Psychiatry; 2009 Jan; 66(1):107-8; author reply 108-9. PubMed ID: 19124694
    [No Abstract]   [Full Text] [Related]  

  • 24. Lorazepam and anticholinergics in tardive akathisia.
    Yassa R; Bloom D
    Biol Psychiatry; 1990 Feb; 27(4):463-4. PubMed ID: 1968768
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inpatient clinical trial of lorazepam for the management of manic agitation.
    Modell JG; Lenox RH; Weiner S
    J Clin Psychopharmacol; 1985 Apr; 5(2):109-13. PubMed ID: 3988969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.
    Ford N; Ludbrook G; Galletly C
    Aust N Z J Psychiatry; 2015 Dec; 49(12):1227. PubMed ID: 26058787
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
    Kwentus J; Riesenberg RA; Marandi M; Manning RA; Allen MH; Fishman RS; Spyker DA; Kehne JH; Cassella JV
    Bipolar Disord; 2012 Feb; 14(1):31-40. PubMed ID: 22329470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
    Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
    J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of improvement in treatment trials of acute mania.
    Barr M
    Aust N Z J Psychiatry; 1991 Dec; 25(4):442, 445. PubMed ID: 1793412
    [No Abstract]   [Full Text] [Related]  

  • 31. Emergency treatment of acute psychosis, agitation, and anxiety.
    Ellison JM
    Hosp Community Psychiatry; 1985 Apr; 36(4):351-2. PubMed ID: 3997094
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
    Owen RT
    Drugs Today (Barc); 2013 Mar; 49(3):195-201. PubMed ID: 23527323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Old drug in new package promises to calm the agitated.
    Morrow T
    Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536
    [No Abstract]   [Full Text] [Related]  

  • 34. Lorazepam in resistant mania.
    Jobling M; Stein G
    Lancet; 1986 Mar; 1(8479):510. PubMed ID: 2869253
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuum of care: stabilizing the acutely agitated patient.
    Bellnier TJ
    Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S12-8. PubMed ID: 12227082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The agitated patient, Part II: Pharmacologic treatment.
    Tesar GE
    Hosp Community Psychiatry; 1993 Jul; 44(7):627-9. PubMed ID: 8354501
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid tranquilization with intramuscular clonazepam.
    Benazzi F; Mazzoli M
    Can J Psychiatry; 1994 Sep; 39(7):451. PubMed ID: 7987793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.